Langat Daudi K, Sue Platt J, Tawfik Ossama, Fazleabas Asgerally T, Hunt Joan S
Department of Anatomy and Cell Biology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160-7400, USA.
J Reprod Immunol. 2006 Aug;71(1):75-86. doi: 10.1016/j.jri.2006.01.006. Epub 2006 Apr 17.
Human leukocyte antigen-G (HLA-G) is a major histocompatibility complex class Ib gene expressed in normal organs and in some tumors. The glycoproteins encoded by this gene are best known for their immunosuppressive properties. Because isoform-specific expression of HLA-G in male reproductive organs has not been reported, we investigated HLA-G1, -G2, -G5, -G6 mRNAs and proteins in four-to-five samples of normal prostate glands, prostates with benign prostatic hyperplasia and prostate adenocarcinomas using RT-PCR and immunohistochemistry. All tissues contained HLA-G1, -G2, -G5 and -G6 specific mRNAs, but only HLA-G5 protein was detectable. In normal prostate glands, HLA-G5 protein was prominent in the cytoplasm of tubuloglandular epithelia and in glandular secretions. Staining was reduced in samples of benign prostatic hyperplasia but remained localized to the cytoplasm of glandular epithelia and secretions. In prostatic adenocarcinomas, HLA-G5 protein was detectable mainly in the secretions. Thus, HLA-G5 but not HLA-G1, -G2 or -G6 is produced in the normal prostate and is present in prostatic secretions. In addition, normal cellular localization is disturbed in benign and malignant prostatic adenocarcinomas. The results are consistent with this molecule may influencing female immune receptivity to sperm and suggest that such immunosuppression could be disturbed in men with prostatic adenocarcinomas.
人类白细胞抗原-G(HLA-G)是一种主要组织相容性复合体I类b基因,在正常器官和某些肿瘤中表达。该基因编码的糖蛋白以其免疫抑制特性而闻名。由于尚未报道HLA-G在男性生殖器官中的异构体特异性表达,我们使用逆转录聚合酶链反应(RT-PCR)和免疫组织化学方法,对4至5份正常前列腺、良性前列腺增生前列腺和前列腺腺癌样本中的HLA-G1、-G2、-G5、-G6信使核糖核酸(mRNA)和蛋白质进行了研究。所有组织均含有HLA-G1、-G2、-G5和-G6特异性mRNA,但仅可检测到HLA-G5蛋白。在正常前列腺中,HLA-G5蛋白在小管腺上皮细胞的细胞质和腺分泌物中显著。在良性前列腺增生样本中染色减少,但仍局限于腺上皮细胞的细胞质和分泌物中。在前列腺腺癌中,HLA-G5蛋白主要在分泌物中可检测到。因此,正常前列腺中产生的是HLA-G5而非HLA-G1、-G2或-G6,且存在于前列腺分泌物中。此外,在良性和恶性前列腺腺癌中正常细胞定位受到干扰。这些结果与该分子可能影响女性对精子的免疫接受性一致,并表明前列腺腺癌男性中这种免疫抑制可能受到干扰。